AnGes - M&A Summary and Business Overview

Life ScienceCompany

AnGes M&A Summary

AnGes has acquired 1 company, including 1 in the last 5 years.

AnGes’ largest acquisition to date was in 2020, when it acquired EmendoBio for $250M. AnGes has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

AnGes Business Overview

Where is AnGes headquartered?

AnGes is headquartered in Ibaraki, Japan.

What is AnGes’ revenue?

AnGes disclosed revenue of 153M JPY for 2023 and 67M JPY for 2022.

How many employees does AnGes have?

AnGes has 145 employees.

What sector is AnGes in?

AnGes is a life science company.

When was AnGes founded?

AnGes was founded in 1999.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

AnGes

AnGes, Inc.

Saito Bio-Incubator, 1st Floor 7-7-15, Saito-asagi,
Ibaraki, 567-0085
Japan,
www.anges.co.jp

AnGes is a biopharmaceutical company focuses on the development of gene‐based medicines. AnGes obtained conditional and time‐limited approval for its lead product, Collategene (Hepatocyte Growth Factor, HGF, plasmid gene therapy), for the treatment of Lower Limb Ischemic Ulcers. In September 2019, AnGes commenced the commercialization in Japan of Collategene . Collategene is the world’s first marketed drug-using Plasmid DNA. AnGes is currently focusing on the development of DNA vaccines for COVID‐19 and Hypertension, Tie2 tyrosine kinase receptor agonist for COVID‐19 treatment, and NF‐κB decoy oligonucleotide for Chronic Discogenic Lumbar Back Pain. AnGes was founded in 1999 and is based in Ibaraki, Japan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - 1 - - - - 1
vol $250M $250M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
EmendoBio, Inc. 2020-12-15 250M USD Add-on Acquisition
New York, New York · www.emendobio.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 250M (100%) - -
Total 1 $250M - -

By Geo

State/Country Buy Value Sell Value
United States 1 250M - -
  New York 1 250M - -
Total 1 $250M - -

Deal Values

buy # Total
$100M to $1B 1 $250M
TOTAL $250M
Largest EmendoBio, Inc.
$250M (2020-12-15)

Company Summary

SECTOR

Life Science

Revenue

153   129% 2023
67   5% 2022
64   60% 2021
40   88% 2020
327   47% 2019
610   68% 2018
365   29% 2017
514   2016
(millions of JPY) Show More Show Less

Employees

145

Established

1999

Public

Tokyo (TSE): 4563

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AnGes

Life Science Companies , Japan Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Japan Companies

Largest Japan Companies , Acquisitive Japan Companies , Recently Acquired Japan Companies , Recently Sold Japan Companies , Private Japan Companies , Public Japan Companies , Acquired Japan Companies , PE Backed Japan Companies
Mergr

Product

Company

Legal